Calcium Antacid (Calcium Carbonate) Recall Due to Blister Packaging Separation
Safecor Health recalls 791 boxes of Calcium Carbonate chewable tablets (Lot 24A0073) due to cGMP deviations where blister card-foils separated from blister cavities.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class II recall for a manufacturing quality control defect (blister packaging separation). No specific hazard indicators such as pathogens, allergens, or reported injuries are mentioned in the source.
Plain-English summary
Safecor Health, LLC has recalled 791 boxes of CALCIUM ANTACID (Calcium Carbonate) Chewable 500 mg tablets due to cGMP manufacturing deviations. The recalled product is identified by lot number 24A0073 with an expiration date of June 28, 2026, and is packaged as a 100-count unit dose box.
During quality control inspections, observations were made that some blister card-foils were separating from the blister cavity. The FDA classified this as a Class II recall.
The affected product was distributed nationwide throughout the United States. Consumers who have purchased this product with the identified lot number should discontinue use and contact their healthcare provider with any concerns.
The recalled product
- Product
- CALCIUM ANTACID (CALCIUM CARBONATE)
- Brand
- CALCIUM ANTACID
- Manufacturer
- Safecor Health, LLC
- Category
- Drug — OTC Antacid
- Hazard
- Affected units
- 791
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot# 24A0073
- exp. date 06/28/2026
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 5 recalled by Safecor Health, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 5 products in this recall →Related recalls
Same manufacturer · Safecor Health, LLC
See all →- ModerateSafecor Health Recalls Fluphenazine HCl Elixir Due to Stability Failures
FDA (Drugs) · 2026-09-23
- ModerateSafecor Health Recalls Fluphenazine HCl Elixir Due to Stability Failures
FDA (Drugs) · 2026-09-23
- ModerateSafecor Health Recalls Fluphenazine HCl Elixir Due to Stability Failures
FDA (Drugs) · 2026-09-23
- ModerateSafecor Health Recalls Fluphenazine HCl Elixir Due to Stability Failures
FDA (Drugs) · 2026-09-23
- ModerateSafecor Health Recalls Fluphenazine HCl Elixir Due to Stability Failures
FDA (Drugs) · 2026-09-23
Same hazard · packaging defect
See all →- High
- SevereSI-BONE iFuse TORQ Implant System Recalled for Sterility Assurance Issues
FDA (Devices) · 2026-10-21
- HighEmbosphere Microspheres Recalled Due to Packaging Sterility Concerns
FDA (Devices) · 2026-10-07
- ModerateAmneal Recalls Estradiol Gel Packets Due to Empty or Partially Full Containers
FDA (Drugs) · 2026-10-07
- ModerateAVID Medical Recalls Halyard IV Start Kits Due to Packaging Seal Issues
FDA (Devices) · 2026-09-30
Similar recalls
- ModerateSafecor Health Recalls Calcium Carbonate and Vitamin D3 Tablets
FDA (Drugs) · 2017-06-21
- HighCalcium Carbonate Oral Suspension Recalled Due to Manufacturing Control Deviations
FDA (Drugs) · 2022-09-14
- HighCareOne extra strength calcium antacid tablets contain metallic particles
FDA (Drugs) · 2026-06-10
- ModerateMagnacal Calcium Carbonate Tablets Recalled for cGMP Deviations
FDA (Drugs) · 2022-02-09
- ModerateTrial Antacid Tablet bulk containers recalled for CGMP deviations
FDA (Drugs) · 2022-02-16
- HighTopCare extra strength antacid tablets contain small metallic particles
FDA (Drugs) · 2026-06-10